Year |
Citation |
Score |
2016 |
Holm CK, Rahbek SH, Gad HH, Bak RO, Jakobsen MR, Jiang Z, Hansen AL, Jensen SK, Sun C, Thomsen MK, Laustsen A, Nielsen CG, Severinsen K, Xiong Y, Burdette DL, et al. Influenza A virus targets a cGAS-independent STING pathway that controls enveloped RNA viruses. Nature Communications. 7: 10680. PMID 26893169 DOI: 10.1038/Ncomms10680 |
0.345 |
|
2015 |
Sreelatha A, Bennett TL, Carpinone EM, O'Brien KM, Jordan KD, Burdette DL, Orth K, Starai VJ. Vibrio effector protein VopQ inhibits fusion of V-ATPase-containing membranes. Proceedings of the National Academy of Sciences of the United States of America. 112: 100-5. PMID 25453092 DOI: 10.1073/Pnas.1413764111 |
0.678 |
|
2013 |
Diner EJ, Burdette DL, Wilson SC, Monroe KM, Kellenberger CA, Hyodo M, Hayakawa Y, Hammond MC, Vance RE. The innate immune DNA sensor cGAS produces a noncanonical cyclic dinucleotide that activates human STING. Cell Reports. 3: 1355-61. PMID 23707065 DOI: 10.1016/J.Celrep.2013.05.009 |
0.62 |
|
2013 |
Barker JR, Koestler BJ, Carpenter VK, Burdette DL, Waters CM, Vance RE, Valdivia RH. STING-dependent recognition of cyclic di-AMP mediates type I interferon responses during Chlamydia trachomatis infection. Mbio. 4: e00018-13. PMID 23631912 DOI: 10.1128/Mbio.00018-13 |
0.683 |
|
2013 |
Conlon J, Burdette DL, Sharma S, Bhat N, Thompson M, Jiang Z, Rathinam VA, Monks B, Jin T, Xiao TS, Vogel SN, Vance RE, Fitzgerald KA. Mouse, but not human STING, binds and signals in response to the vascular disrupting agent 5,6-dimethylxanthenone-4-acetic acid. Journal of Immunology (Baltimore, Md. : 1950). 190: 5216-25. PMID 23585680 DOI: 10.4049/Jimmunol.1300097 |
0.665 |
|
2013 |
Burdette DL, Vance RE. STING and the innate immune response to nucleic acids in the cytosol. Nature Immunology. 14: 19-26. PMID 23238760 DOI: 10.1038/Ni.2491 |
0.648 |
|
2013 |
Leong M, Kanne D, Glickman L, Lemmens E, Lauer P, Metchette K, Burdette D, Diner E, Fu J, Soares K, Brockstedt D, Portnoy D, Vance R, Kim Y, Jaffee E, et al. Modified STING-activating cyclic dinucleotide derivatives significantly enhance the anti-tumor activity of therapeutic vaccines Journal For Immunotherapy of Cancer. 1: O20. DOI: 10.1186/2051-1426-1-S1-O20 |
0.716 |
|
2011 |
Burdette DL, Monroe KM, Sotelo-Troha K, Iwig JS, Eckert B, Hyodo M, Hayakawa Y, Vance RE. STING is a direct innate immune sensor of cyclic di-GMP. Nature. 478: 515-8. PMID 21947006 DOI: 10.1038/Nature10429 |
0.76 |
|
2009 |
Burdette DL, Seemann J, Orth K. Vibrio VopQ induces PI3-kinase-independent autophagy and antagonizes phagocytosis. Molecular Microbiology. 73: 639-49. PMID 19627496 DOI: 10.1111/J.1365-2958.2009.06798.X |
0.57 |
|
2009 |
Burdette DL, Yarbrough ML, Orth K. Not without cause: Vibrio parahaemolyticus induces acute autophagy and cell death. Autophagy. 5: 100-2. PMID 19011375 DOI: 10.4161/Auto.5.1.7264 |
0.54 |
|
2008 |
Burdette DL, Yarbrough ML, Orvedahl A, Gilpin CJ, Orth K. Vibrio parahaemolyticus orchestrates a multifaceted host cell infection by induction of autophagy, cell rounding, and then cell lysis. Proceedings of the National Academy of Sciences of the United States of America. 105: 12497-502. PMID 18713860 DOI: 10.1073/Pnas.0802773105 |
0.56 |
|
2008 |
Hao YH, Wang Y, Burdette D, Mukherjee S, Keitany G, Goldsmith E, Orth K. Structural requirements for Yersinia YopJ inhibition of MAP kinase pathways. Plos One. 3: e1375. PMID 18167536 DOI: 10.1371/Journal.Pone.0001375 |
0.568 |
|
2007 |
Liverman ADB, Cheng HC, Trosky JE, Leung DW, Yarbrough ML, Burdette DL, Rosen MK, Orth K. Arp2/3-independent assembly of actin by Vibrio type III effector VopL Proceedings of the National Academy of Sciences of the United States of America. 104: 17117-17122. PMID 17942696 DOI: 10.1073/Pnas.0703196104 |
0.545 |
|
2004 |
Trosky JE, Mukherjee S, Burdette DL, Roberts M, McCarter L, Siegel RM, Orth K. Inhibition of MAPK signaling pathways by VopA from Vibrio parahaemolyticus. The Journal of Biological Chemistry. 279: 51953-7. PMID 15459200 DOI: 10.1074/Jbc.M407001200 |
0.612 |
|
Low-probability matches (unlikely to be authored by this person) |
2006 |
Rothberg KG, Burdette DL, Pfannstiel J, Jetton N, Singh R, Ruben L. The RACK1 homologue from Trypanosoma brucei is required for the onset and progression of cytokinesis. The Journal of Biological Chemistry. 281: 9781-90. PMID 16469736 DOI: 10.1074/Jbc.M600133200 |
0.254 |
|
2017 |
Niu C, Livingston CM, Li L, Beran RK, Daffis S, Ramakrishnan D, Burdette D, Peiser L, Salas E, Ramos H, Yu M, Cheng G, Strubin M, Delaney Iv WE, Fletcher SP. The Smc5/6 Complex Restricts HBV when Localized to ND10 without Inducing an Innate Immune Response and Is Counteracted by the HBV X Protein Shortly after Infection. Plos One. 12: e0169648. PMID 28095508 DOI: 10.1371/journal.pone.0169648 |
0.22 |
|
2021 |
Liu Y, Chang S, Hsieh D, Burdette D, Martin R, Mo H, Feierbach B. Generation of an HBV Core Phenotyping Assay for Evaluating HBV Capsid Compounds. Journal of Virological Methods. 114117. PMID 33657432 DOI: 10.1016/j.jviromet.2021.114117 |
0.167 |
|
2022 |
Burdette D, Hyrina A, Song Z, Beran RK, Cheung T, Gilmore S, Kobayashi T, Li L, Liu Y, Niedziela-Majka A, Medley J, Mehra U, Morganelli P, Novikov N, Niu C, et al. Characterization of a Novel Capsid Assembly Modulator for the Treatment of Chronic Hepatitis B Virus Infection. Antimicrobial Agents and Chemotherapy. e0134822. PMID 36519892 DOI: 10.1128/aac.01348-22 |
0.162 |
|
2020 |
Hong X, Luckenbaugh L, Mendenhall M, Walsh R, Cabuang L, Soppe S, Revill P, Burdette D, Feierbach B, Delaney W, Hu J. Characterization of Hepatitis B Precore/Core-Related Antigens. Journal of Virology. PMID 33148795 DOI: 10.1128/JVI.01695-20 |
0.161 |
|
2022 |
Hyrina A, Burdette D, Song Z, Ramirez R, Okesli-Armlovich A, Vijayakumar A, Bates J, Trevaskis JL, Fletcher SP, Lee WA, Holdorf MM. Targeting lipid biosynthesis pathways for hepatitis B virus cure. Plos One. 17: e0270273. PMID 35925919 DOI: 10.1371/journal.pone.0270273 |
0.158 |
|
2019 |
Wang S, Fogeron ML, Schledorn M, Dujardin M, Penzel S, Burdette D, Berke JM, Nassal M, Lecoq L, Meier BH, Böckmann A. Combining Cell-Free Protein Synthesis and NMR Into a Tool to Study Capsid Assembly Modulation. Frontiers in Molecular Biosciences. 6: 67. PMID 31440516 DOI: 10.3389/fmolb.2019.00067 |
0.152 |
|
2022 |
Burdette DL, Lazerwith S, Yang J, Chan HLY, Delaney Iv WE, Fletcher SP, Cihlar T, Feierbach B. Ongoing viral replication and production of infectious virus in patients with chronic hepatitis B virus suppressed below the limit of quantitation on long-term nucleos(t)ide therapy. Plos One. 17: e0262516. PMID 35363817 DOI: 10.1371/journal.pone.0262516 |
0.128 |
|
2023 |
Lecoq L, Brigandat L, Huber R, Fogeron ML, Wang S, Dujardin M, Briday M, Wiegand T, Callon M, Malär A, Durantel D, Burdette D, Berke JM, Meier BH, Nassal M, et al. Molecular elucidation of drug-induced abnormal assemblies of the hepatitis B virus capsid protein by solid-state NMR. Nature Communications. 14: 471. PMID 36709212 DOI: 10.1038/s41467-023-36219-3 |
0.126 |
|
2024 |
Kornyeyev D, Song Z, Eng S, Soulette C, Ramirez R, Tang J, Yue Q, Subramanian R, Zaboli S, Moon C, Tam J, Brodbeck J, Aggarwal A, Diehl L, Fletcher SP, ... ... Burdette D, et al. Selective depletion of HBV-infected hepatocytes by class A capsid assembly modulators requires high levels of intrahepatic HBV core protein. Antimicrobial Agents and Chemotherapy. e0042024. PMID 38780261 DOI: 10.1128/aac.00420-24 |
0.12 |
|
2019 |
Burdette D, Cathcart A, Shauf A, Win R, Zaboli S, Hedskog C, Svarovskaia ES, Barry V, Inzunza D, Flaherty JF, Gaggar A, Fletcher S, Chan H, Mo H, Lazerwith S, et al. PS-150-Evidence for the presence of infectious virus in the serum from chronic hepatitis B patients suppressed on nucleos (t)ide therapy with detectable but not quantifiable HBV DNA Journal of Hepatology. 70: e95. DOI: 10.1016/S0618-8278(19)30168-9 |
0.106 |
|
Hide low-probability matches. |